Haematology

Development of biosimilar medicines

Biosimilar medicines are used to treat the same diseases in the same way

A biosimilar medicine is a highly similar version of an original brand of a biological medicine, brought to market by a different manufacturer once the patent on the original brand expires.

Haematologist

Prof Szer has particular expertise in malignant haematology and haemopoietic stem cell transplantation, which he established as a form of therapy in Victoria in the early 1980s.

VIEW NOW

Approval of biological medicines

Australia has a strong regulatory system for all medicines

Australia has a strong regulatory system that ensures the safety, effectiveness and quality of all medicines, including biological medicines.